Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7

Drug Metabolism and Disposition

Volumn 30, Issue 8, 2002, Pages 883-891

  Andrew Williams, J ^a,b   Ring, Barbara J ^a,b   Cantrell, Varon E ^a,b   Jones, David R ^a,b   Eckstein, James ^a,b   Ruterbories, Kenneth ^a,b   Hamman, Mitchell A ^a,b   Hall, Stephen D ^a,b   Wrighton, Steven A ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; CLARITHROMYCIN; CYTOCHROME B5; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; CYTOCHROME P450 REDUCTASE; MIDAZOLAM; N NORDILTIAZEM; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; CATALYSIS; CHEMICAL REACTION KINETICS; COMPARATIVE STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; METABOLITE; OXIDATION; PRIORITY JOURNAL;

ALPRAZOLAM; ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; CLARITHROMYCIN; COUMARINS; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; DILTIAZEM; ESTRADIOL; HUMANS; KINETICS; MICROSOMES, LIVER; MIDAZOLAM; NIFEDIPINE; TAMOXIFEN; TESTOSTERONE; TRIAZOLAM;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0036320872     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.8.883     Document Type: Article

References (32)

1. Allosteric behavior in cytochrome p450-dependent in vitro drug-drug interactions: A prospective based on conformational dynamics
2. Pharmacokinetics
3. cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450
4. Phenylalaninc and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity
5. 324Pro) expressed by recombinant baculovirus in insect cells
6. Genomic organization of the human CYP3A locus: Identification of a new, inducible CYP3A gene
7. Expression of cytochrome P450 3A5 in Escherichia coli: Effects of 5′ modification, purification, spectral characterization, reconstitution conditions and catalytic activities
8. Expression of cytochrome P450 3A7 in Escherichia coli: Effects of 5′ modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase
9. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily
10. Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
11. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model
12. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation
13. CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates
14. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin
15. Drug-drug interactions: Effect of quinidine on nifedipine binding to human cytochrome P450 3A4
16. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites
17. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
18. Characterization of the NADPH-dependent metabolism of 17 beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5
19. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: The effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosteronc
20. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
21. In vitro metabolism of zatosetron. Interspecics comparison and role of CYP 3A
22. Studies on the interactions between drugs and estrogen: Analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase
23. Topological alteration of the CYP3A4 active site by the divalent cation Mg(2+)
24. Triazolam substrate inhibition: Evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site
25. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
26. Substrate-dependent modulation of CYP3A4 catalytic activity: Analysis of 27 test compounds with four fluorometric substrates
27. Interaction of diclofcnac and quinidine in monkeys: Stimulation of diclofenac metabolism
28. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer
29. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)
30. Identification of a polymorphically expressed member of the human cytochrome P-450III family